💡 Despite guideline-directed therapies, including SGLT2 inhibitors, a significant residual risk remains in patients with heart failure with mildly reduced and preserved EF. 📈 Explore clinical trials data in this series for insights on optimising treatments and patient outcomes 🔗 https://ow.ly/siTy50TIAMv This programme is supported by an unrestricted educational grant from Bayer. This education was developed by Radcliffe Medical Communications (Eire) Ltd. #HeartFailure #CardioVascular #Cardiology
Radcliffe Medical Education
E-learning
Bourne End, Buckinghamshire 430 followers
We bring medical knowledge, insight & innovation to life for cardiovascular, renal & metabolic clinicians globally.
About us
We bring medical education to life. We're here to bring medical knowledge, insight and innovation to life for cardiovascular and Renal and Metabolic clinicians around the world, to help transform theory into practice faster and more effectively. We do this by: We only deal with the latest and best evidence. We adhere to the highest international standards of scientific research. We work hands-on with our community. We are here to serve the knowledge needs of working clinicians around the world. We make the knowledge you need user-friendly and practical. We bring fresh thinking. Bringing insight and innovation to life takes imagination and energy. In our fast-changing world, where sharing knowledge effectively has never been more important. We're on a mission to find new ways of framing, new formats and platforms, new styles and structures, new ways to cut through the noise and inspire.
- Website
-
https://www.radcliffemedicaleducation.org
External link for Radcliffe Medical Education
- Industry
- E-learning
- Company size
- 11-50 employees
- Headquarters
- Bourne End, Buckinghamshire
- Type
- Privately Held
- Founded
- 2013
- Specialties
- cardiology, cardiovascular education, CME courses, Broadcasts, heart failure, heart disease, cardiovascular disease, vascular, events, medical education, medical communication, electrophsyiology, interventional cardiology, digital publishing, webinars, interviews, medical research, cardiology education, e-learning, and accredited education
Locations
-
Primary
Get directions
Bourne End, Buckinghamshire SL8 5AS, GB
Employees at Radcliffe Medical Education
Updates
-
What are the biggest challenges cardiologists face when diagnosing and managing ATTR-CM? 🔗 https://ow.ly/3tKo50TGFPt Join Pr Thibaud DAMY as he leads an expert panel featuring Dr Esther Herrán González, Dr João Agostinho, and Dr Ahmad Masri as they discuss: 🌟 Diagnosing ATTR in regular cardiac clinics 🌟 Managing mixed phenotypes 🌟 Exploring new treatment options This Satellite Symposium was supported by an unrestricted educational grant from AstraZeneca who had no involvement in the content. #Cardiology #ATTRCM #HeartFailure
-
-
Calling all: 🫀 Cardiologists ❤️🩹 Heart Failure Specialists 🩺 Nephrologists 👩⚕️👨⚕️ Primary Care Physicians 📚 Join Dr Anjay Rastogi and Dr Clara Bonanad Lozano as they share insights on optimising hyperkalaemia management in heart failure and chronic kidney disease 🔗 https://ow.ly/V5oT50TrOkp This programme is supported by an unrestricted educational grant from AstraZeneca. #HeartFailure #Hyperkalaemia #RAASi
-
-
🚩 What are the "red flags" to look out for when diagnosing cardiac amyloidosis? 👉 Watch this #ATTR-CM series to learn how HCPs can drive early detection for optimal results 🔗 https://ow.ly/mCPA50TzLJ1 This activity is supported by an unrestricted educational grant from AstraZeneca. AstraZeneca has had no involvement in the selection of the speakers, the development of the activity, the agenda or the materials. #CardioVascular #MedicalEducation
-
📊 Trial data reveals that patients who discontinued RAASi therapy faced a 74% risk of ESKD progression, while those who down-titrated saw a 60% risk. What can HCPs do to manage the significant link between hyperkalaemia and ESKD? 💡 Find out more and explore effective strategies in this video series on hyperkalaemia 🔗 https://ow.ly/lQP750TrNPj This programme is supported by an unrestricted educational grant from AstraZeneca. #HeartFailure #Hyperkalaemia #RAASi
-
Radcliffe Medical Education reposted this
🎉 We are pleased to announce the launch of Radcliffe CVRM, a new platform dedicated to supporting healthcare professionals in managing cardiovascular, renal, and metabolic conditions. By bringing together experts from multiple specialities, Radcliffe CVRM will deliver timely, relevant and impactful clinical insights to improve patient outcomes. Learn more about our mission and how we're shaping the future of healthcare at https://lnkd.in/etfNA4nd Read more from our press release here: https://lnkd.in/e_tRiwUi #CardioVascular #Nephrology #Endocrinology #HealthcareInnovation
-
-
⏰ Reminder: Don’t miss out on this video series featuring Prof Giuseppe Rosano, Dr Lisa Anderson and Prof Antoni Bayes-Genis as they share groundbreaking heart failure data from #HFA2024. See how real-world insights are transforming heart failure care 🔗 https://ow.ly/7FYA50TeeIQ What You'll Lean: 💫 New trends in HF care 💫 Practical tips for quicker diagnosis 💫 Expert advice to elevate your practice This programme is supported by an unrestricted educational grant from AstraZeneca. #HeartFailure #MedicalEducation #CardioVascular
-
-
🥼 Dr Anjay Rastogi discusses the impact of decreasing or discontinuing #RASSI treatment within three months after a hyperkalaemia episode, highlighting this strategy as "depriving patients of life-saving, organ-saving therapy." 🌟 Watch our video series to learn how potassium binder can help optimise RAASi therapy 🔗 https://ow.ly/1wXI50TqLS3 This programme is supported by an unrestricted educational grant from AstraZeneca. #hyperkalaemia #PotassiumBinders #HeartFailure
-
🫀 Recorded live at #HFA2024 this exclusive discussion with Prof Giuseppe Rosano, Dr Lisa Anderson and Prof Antoni Bayes-Genis dives into the latest real-world data on heart failure. Discover how these findings are transforming the future of #HeartFailure care 🔗 https://ow.ly/2m8T50Te7VO Why Watch? 🌟 Gain insights from real-world data 🌟 Understand the latest trends in HF management 🌟 Apply expert advice to enhance your practice This programme is supported by an unrestricted educational grant from AstraZeneca. #Cardiology #HeartHealth
-
-
How many HFrEF patients do you actively treat with medication on a weekly basis? A) <10 B) 11-20 C) 21-30 D) 31 + 💡 Please help us by completing our 5 minute survey on trends and attitudes to heart failure medication 🔗 https://ow.ly/CRrS50SWvMj This survey is supported by Servier and designed and disseminated by Radcliffe Medical Education. #HeartFailure #CardiologySurvey #MedicalResearch #HeartHealth
-